This contract expires in 18 days (Sep 30, 2026).
SOFIE CO. - PHARMACEUTICALS NEEDED FOR PATIENT CARE.
Key Details
Description
PHARMACEUTICALS NEEDED FOR PATIENT CARE.
Context & Analysis
On Nov 4, 2025, Department of Defense obligated $36,087.2 to SOFIE CO. for pharmaceuticals needed for patient care.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in STERLING, VA. The contract is scheduled through Sep 30, 2026 — approximately 1 month remaining. This award is one of several similar procurements from Department of Defense under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
LUTATHERA AND PLUVICTO
NOVARTIS PHARMACEUTICALS CORPORATION
$3.2M
8511784063!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$2.0M
8511784064!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$1.3M
4569692252!RSDL
CANADIAN COMMERCIAL CORPORATION
$747,796
8511784112!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$660,627.72
Stay Updated
Get notified about new opportunities matching your interests.